First-line treatment of chronic lymphocytic leukemia with ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab: final analysis of the randomized, phase 3 iLLUMINATE trial

Autor:	Hsu, Emily, Dai, Sandra, Kwei, Kevin, Gribben, John G, Strugov, Vladimir, Gill, Devinder, Novak, Jan, Simkovic, Martin, Larratt, Loree, Anz, Bertrand, Tedeschi, Alessandra, Greil, Richard, Moreno, Carol, Demirkan, FATİH, Flinn, Ian W, Dean, James P
Jazyk:	angličtina
Rok vydání:	2022
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=od______2605::53e8b662705e60a4fb8aac8fbc412220 https://avesis.deu.edu.tr/publication/details/9ab9c097-5545-4e66-8616-f5313b11d2ff/oai Zobrazit plný text záznamu